Literature DB >> 21818134

Hemoglobin AC retinopathy managed with vitrectomy and adjunctive bevacizumab.

R Pokroy, U R Desai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21818134      PMCID： PMC3213652          DOI： 10.1038/eye.2011.189

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  An update on vitrectomy surgery and retinal detachment repair in sickle cell disease.

Authors:  L M Jampol; J L Green; M F Goldberg; G A Peyman
Journal:  Arch Ophthalmol       Date:  1982-04

2.  Sickle-cell hemoglobin and its relation to fundus abnormality.

Authors:  R B Welch; M F Goldberg
Journal:  Arch Ophthalmol       Date:  1966-03

3.  Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy.

Authors:  Rubens C Siqueira; Rogério A Costa; Ingrid U Scott; Léssia P Cintra; Rodrigo Jorge
Journal:  Acta Ophthalmol Scand       Date:  2006-12

4.  Retinopathy in patients with sickle cell trait.

Authors:  Sherrol A Reynolds; Eulogio Besada; Christine Winter-Corella
Journal:  Optometry       Date:  2007-11

5.  Retinopathy in haemoglobin C trait.

Authors:  M Hingorani; C R Bentley; H Jackson; F Betancourt; R Arya; W A Aclimandos; A C Bird
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.